DrugEx
The premium Open Source alternative to Iktos Makya
🎯 Best for:Multi-objective optimization of molecules using RL.
What is DrugEx?
Replaces proprietary drug discovery AI platforms. It combines reinforcement learning with sequence-based models to optimize molecules for specific targets.
Tech Stack
Jupyter NotebookPharma & Biotechnology
Why DrugEx?
- • Multi-objective optimization
- • Transformer support
- • RL-driven
Limitations
- • Training instability
- • High memory usage
- • Complex reward shaping
3/3/2026
Last Update
26
Forks
5
Issues
MIT
License
Financial Leak Detected
Stop the "SaaS Tax"
Your team could be burning cash. Switching to DrugEx instantly boosts your runway.
Competitor Cost
-$1,440
/ year (est. based on Iktos Makya)
Self-Hosted
$0
/ year
Team Size10 Users
150+
SAVE 100%